Clinical Trial Update: Compassionate Use of Omegaven to Reverse Parenteral Nutrition Induced Cholestasis [NA]

View source ↗

Summary

A completed clinical trial investigating compassionate use of Omegaven to reverse parenteral nutrition–induced cholestasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholestasis

Drugs mentioned

• Omegaven (fish oil-based intravenous fat emulsion)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Cholestasis | NA | Status: COMPLETED | Results posted: 2020-05-08